These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 24224626)

  • 1. Clinical practice: Adult attention deficit-hyperactivity disorder.
    Volkow ND; Swanson JM
    N Engl J Med; 2013 Nov; 369(20):1935-44. PubMed ID: 24224626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The MTA at 8.
    Pliszka SR
    J Am Acad Child Adolesc Psychiatry; 2009 Nov; 48(11):1122. PubMed ID: 19855222
    [No Abstract]   [Full Text] [Related]  

  • 3. The MTA at 8.
    Banaschewski T; Buitelaar J; Coghill DR; Sergeant JA; Sonuga-Barke E; Zuddas A; Taylor E;
    J Am Acad Child Adolesc Psychiatry; 2009 Nov; 48(11):1120-1122. PubMed ID: 19855221
    [No Abstract]   [Full Text] [Related]  

  • 4. Sensitivity of parent reports in the MTA.
    Tryon WW
    J Am Acad Child Adolesc Psychiatry; 2009 Nov; 48(11):1124. PubMed ID: 19855224
    [No Abstract]   [Full Text] [Related]  

  • 5. Adult attention deficit/hyperactivity disorder in the ambulatory care setting.
    Hackett A; Joseph R; Robinson K; Welsh J; Nicholas J; Schmidt E
    JAAPA; 2020 Aug; 33(8):12-16. PubMed ID: 32740107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Attention deficit hyperactivity disorders in children and adolescents: diagnostic and therapeutic guidelines].
    Lehmkuhl G
    MMW Fortschr Med; 2007 May; 149 Suppl 2():10-3; quiz 14. PubMed ID: 17724960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A head-to-head randomized clinical trial of methylphenidate and atomoxetine treatment for executive function in adults with attention-deficit hyperactivity disorder.
    Ni HC; Shang CY; Gau SS; Lin YJ; Huang HC; Yang LK
    Int J Neuropsychopharmacol; 2013 Oct; 16(9):1959-73. PubMed ID: 23672818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological treatment of attention-deficit/hyperactivity disorder in adults.
    Slatkoff J; Greenfield B
    Expert Opin Investig Drugs; 2006 Jun; 15(6):649-67. PubMed ID: 16732717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative benefits and harms of competing medications for adults with attention-deficit hyperactivity disorder: a systematic review and indirect comparison meta-analysis.
    Peterson K; McDonagh MS; Fu R
    Psychopharmacology (Berl); 2008 Mar; 197(1):1-11. PubMed ID: 18026719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [My child is so restless].
    Schlamp D
    MMW Fortschr Med; 2007 Mar; 149(10):39-40. PubMed ID: 17408047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Close up on atomoxetine: a nonstimulant choice for treating ADHD.
    Allen C; Pitcock J
    Adv Nurse Pract; 2006 Mar; 14(3):39-40, 42-3, 78. PubMed ID: 16548127
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacotherapy of ADHD in adults.
    Wilens TE
    CNS Spectr; 2008 May; 13(5 Suppl 8):11-3. PubMed ID: 18567133
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy and tolerability of pharmacotherapies for attention-deficit hyperactivity disorder in adults.
    Santosh PJ; Sattar S; Canagaratnam M
    CNS Drugs; 2011 Sep; 25(9):737-63. PubMed ID: 21870887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health care costs of adults treated for attention-deficit/hyperactivity disorder who received alternative drug therapies.
    Wu EQ; Birnbaum HG; Zhang HF; Ivanova JI; Yang E; Mallet D
    J Manag Care Pharm; 2007 Sep; 13(7):561-9. PubMed ID: 17874862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [ADHD in children and adults].
    Thomsen PH; Plessen KJ; Houmann T
    Ugeskr Laeger; 2014 Jul; 176(28):V11120664. PubMed ID: 25292000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Switching from neurostimulant therapy to atomoxetine in children and adolescents with attention-deficit hyperactivity disorder : clinical approaches and review of current available evidence.
    Prasad S; Steer C
    Paediatr Drugs; 2008; 10(1):39-47. PubMed ID: 18162007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic review of combination therapy with stimulants and atomoxetine for attention-deficit/hyperactivity disorder, including patient characteristics, treatment strategies, effectiveness, and tolerability.
    Treuer T; Gau SS; Méndez L; Montgomery W; Monk JA; Altin M; Wu S; Lin CC; Dueñas HJ
    J Child Adolesc Psychopharmacol; 2013 Apr; 23(3):179-93. PubMed ID: 23560600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Updates on attention deficit hyperactivity disorder, child abuse and neglect, and sudden infant death syndrome.
    Daley KC
    Curr Opin Pediatr; 2003 Apr; 15(2):216-25. PubMed ID: 12640282
    [No Abstract]   [Full Text] [Related]  

  • 19. Atomoxetine versus stimulants for treatment of attention deficit/hyperactivity disorder.
    Gibson AP; Bettinger TL; Patel NC; Crismon ML
    Ann Pharmacother; 2006 Jun; 40(6):1134-42. PubMed ID: 16735655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term efficacy and safety of treatment with stimulants and atomoxetine in adult ADHD: a review of controlled and naturalistic studies.
    Fredriksen M; Halmøy A; Faraone SV; Haavik J
    Eur Neuropsychopharmacol; 2013 Jun; 23(6):508-27. PubMed ID: 22917983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.